FRA:MRK

MERCK Kommanditgesellschaft auf Aktien - MRK Stock Forecast, Price & News

€165.05

-2.45 (-1.46%)

(As of 03/22/2023 12:00 AM ET)

Add

Compare

Today's Range: €164.65
▼
€167.30
50-Day Range: €163.70
▼
€201.10
52-Week Range: €76.60
▼
€115.00

Volume: 236,853 shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About MERCK Kommanditgesellschaft auf Aktien (FRA:MRK) Stock

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.

Receive MRK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MERCK Kommanditgesellschaft auf Aktien and its competitors with MarketBeat's FREE daily newsletter.

MRK Stock News Headlines

January 9, 2023 | thestreet.com

Why Merck (MRK) Stock Is Falling In Pre-Market Trading Today

December 23, 2022 | finance.yahoo.com

Merck KGaA inks deal worth up to $830M with Cambridge cancer biotech

March 23, 2023 | Legacy Research (Affiliate) (Ad)

"Prepare for Five Years of Famine"

Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast

September 23, 2022 | seekingalpha.com

MRK Merck & Co., Inc.

August 31, 2022 | finance.yahoo.com

MERCK Kommanditgesellschaft auf Aktien (MRK.MI)

August 8, 2022 | finance.yahoo.com

MERCK Kommanditgesellschaft auf Aktien (MRK.F)

July 13, 2022 | finance.yahoo.com

Scientists Get $1 Million Prize to Fight Climate Change With ‘Photosynthesis 2.0’

May 31, 2022 | finance.yahoo.com

Germany's Merck to open semiconductor base in China

March 23, 2023 | Legacy Research (Affiliate) (Ad)

"Prepare for Five Years of Famine"

Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast

May 13, 2022 | seekingalpha.com

Merck KGaA (MKGAF) CEO Belén Garijo on Q1 2022 Results - Earnings Call Transcript

December 14, 2021 | finance.yahoo.com

German chip chemical supplier Merck to invest 500 million euros in Taiwan

November 11, 2021 | ca.finance.yahoo.com

Merck says making progress on meeting surge in lab gear demand

September 17, 2021 | finance.yahoo.com

Supply fears lead EU vaccine industry to seek home comforts

June 29, 2021 | finance.yahoo.com

MORNING BID-A tense finish

June 21, 2021 | finance.yahoo.com

Signature Resources Announces $3.5 Million Non-Brokered Private Placement LED by Commodity Discovery Fund, Funds Managed by Sprott Asset Management LP & Crescat Capital

June 9, 2021 | finance.yahoo.com

This New Product Is Central to mRNA Vaccines -- But Should You Buy the Stock?

May 12, 2021 | finance.yahoo.com

UPDATE 1-Lab supplier Merck KGaA says U.S. Defense Production Act poses challenge

March 25, 2021 | finance.yahoo.com

MORNING BID-Covid, missiles and tanker tailbacks

March 11, 2021 | ca.finance.yahoo.com

MERCK Kommanditgesellschaft auf Aktien (MRK1N.MX)

March 4, 2021 | finance.yahoo.com

Germany's Merck KGaA predicts earnings gain in 2021 on lab gear

December 27, 2020 | marketwatch.com

Hydrophobic Interaction Chromatography Resins Market (2020-29): Demand and Scope, Industry Trends and Threats | Tosoh Corporation, Pall Corporation

December 25, 2020 | marketwatch.com

Superdisintegrants Market (2020-29): Extensive Growth, Rising Demand and Strategies | BASF SE, DFE Pharma

November 14, 2020 | finance.yahoo.com

MERCK Kommanditgesellschaft auf Aktien: Merck KGaA Benefiting From COVID-Related Development Projects; Maintaining Fair Value Estimate

November 3, 2020 | markets.businessinsider.com

Digital Leaders from Almirall and Merck KGaA, Darmstadt, Germany to Keynote Veeva Summit Online, Europe

October 31, 2020 | seekingalpha.com

Merck sets ultra-high bar with impressive development of Keytruda

October 30, 2020 | seekingalpha.com

Merck sets ulta-high bar with impressive development of Keytruda

October 28, 2020 | seekingalpha.com

Merck EPS beats by $0.31, beats on revenue

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive MRK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MERCK Kommanditgesellschaft auf Aktien and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: FRA
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Sector: Medical
Current Symbol: FRA:MRK
CUSIP: N/A
CIK: N/A
Web: www.merckgroup.com
Phone: +49-6151-720
Fax: N/A
Employees: 60,334
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Optionable
Beta: N/A

Key Executives

Ms. Belen Garijo Lopez M.D. (Age 63)
Chair of Exec. Board & CEO
Comp: $5.47M

Dr. Marcus Kuhnert (Age 55)
CFO & Member of Exec. Board
Comp: $4.29M

Dr. Kai Beckmann (Age 58)
CEO of Electronics & Member of the Exec. Board
Comp: $4.31M

Mr. Peter Guenter (Age 61)
CEO of Healthcare Bus. & Member of Exec. Board
Comp: $2.12M

Dr. Matthias J. Heinzel (Age 56)
CEO of Life Science Sector & Member of Exec. Board
Comp: $1.61M

Mr. Gerhard Schmitz (Age 60)
Head of Global Accounting

Mr. Dirk Toepfer
Chief Information Officer

Mr. Constantin Fest (Age 46)
Head of Investor Relations

Dr. Friederike Rotsch (Age 51)
Group Gen. Counsel and Head of Group Legal & Compliance

Ms. Barbara Weiland (Age 49)
Chief Compliance Officer

Key Competitors

View All Competitors

MRK Stock - Frequently Asked Questions

How have MRK shares performed in 2023?: MERCK Kommanditgesellschaft auf Aktien's stock was trading at €180.90 on January 1st, 2023. Since then, MRK shares have decreased by 8.8% and is now trading at €165.05.
View the best growth stocks for 2023 here.
What other stocks do shareholders of MERCK Kommanditgesellschaft auf Aktien own?: Based on aggregate information from My MarketBeat watchlists, some companies that other MERCK Kommanditgesellschaft auf Aktien investors own include Micron Technology (MU), NVIDIA (NVDA), QUALCOMM (QCOM), Abbott Laboratories (ABT), Cisco Systems (CSCO), Gilead Sciences (GILD), Advanced Micro Devices (AMD), Boeing (BA), CVS Health (CVS) and Eli Lilly and (LLY).

What is MERCK Kommanditgesellschaft auf Aktien's stock symbol?: MERCK Kommanditgesellschaft auf Aktien trades on the FRA under the ticker symbol "MRK."
What is MERCK Kommanditgesellschaft auf Aktien's stock price today?: One share of MRK stock can currently be purchased for approximately €165.05.
How many employees does MERCK Kommanditgesellschaft auf Aktien have?: The company employs 60,334 workers across the globe.
How can I contact MERCK Kommanditgesellschaft auf Aktien?: MERCK Kommanditgesellschaft auf Aktien's mailing address is Frankfurter Strasse 250, DARMSTADT, 64293, Germany. The official website for the company is www.merckgroup.com. The healthcare company can be reached via phone at +49-6151-720.

This page (FRA:MRK) was last updated on 3/23/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial